Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events groundbreaking method dealing missing patient reported outcome pro data oncology
… Pharmacovigilance Congress 2023. The role of real-world data and methods in evaluating the safety of medical …
… that Carla (DeMuro) Romano, M.S., Vice President of Patient-Centered Outcomes Assessment at RTI Health Solutions, … session, Romano will be part of the discussion surrounding patient committee participants on the FDA-sponsored study to adapt an in-clinic outcome assessment tool for ALS to remote-use at home. …
… breast cancer. The research also identified several patient-level factors and social determinants of health as …
Navigating EU Joint Clinical Assessments and Joint Scientific Consultations From January 2025 Onward
… From January 2025 Onward Emma Hawe, MSc Head, Data Analytics and Design Strategy RTI Health Solutions … is subject to the EU HTAR, which applies to all new oncology drugs and cell and gene therapies from January 2025, … studies. This includes fundamental criteria, such as patient populations, comparator selection, relevant …
… presented at ESMO Gastrointestinal Cancers Congress 2024 Patient-reported tolerability of sotorasib (soto) and panitumumab …
… in various therapeutic areas, including rare diseases, oncology, and women’s health. The purpose of this article is … may view it as an opportunity to present as much clinical data as early as possible. These objectives may also differ … summaries and evidence tables). Takeaway 4: Provide patient utilization projections While early dossiers will …
… Shahnaz Khan Market Access and Outcomes Strategy Oncology Hematology Gastroenterology Headquarters - Research … disease, endocrinology, urology, gynecology, oncology, hematology, neurology, and gastroenterology. In … regular basis in order to remain up-to-date on the latest news regarding AMCP dossiers. …
Vagus Nerve Stimulation: Cost-Effective Treatment for Drug-Resistant Epilepsy Share on: September 17, 2018 Patients with drug-resistant epilepsy (DRE) utilize more health care resources and face higher costs than patients who can control their condition …
… review process, we can perform meta-analyses when suitable data are found in the literature review. Three standard … clinical development programs. Incidence of adverse events among a patient population or those taking a certain drug. Review of …
… to enhance readability. Use tables and figures to convey data when possible. Update the dossier when there are … guidelines, new RWE, or new phase 3 clinical trial data. Include internal and external hyperlinking. This … important timeline information and information relevant to patient access. Include RWE that contributes significantly to …